Acta Scientific Pharmacology (ASPC)

Letter to Editor Volume 1 Issue 2

Potential Sunset of 2-Year Carcinogenicity Studies in Rodents for Small Molecule Pharma Compounds

KS Rao*

Chief Scientific Officer, Rao Toxicology Foundation, Bangalore, Karnataka, India

*Corresponding Author: KS Rao, Chief Scientific Officer, Rao Toxicology Foundation, Bangalore, Karnataka, India.

Received: January 28, 2020; Published: January 31, 2020

×

  Toxicity/carcinogenicity studies in rodents have played a pivotal role in identifying chemicals that are potentially hazardous to humans. In fact, nearly all of the known human carcinogens are also carcinogenic in 1 or more rodent species. During the past 20 years, the quality and consistency of rodent studies has improved considerably, and much has been learned about mechanisms whereby chemicals initiate or promote the carcinogenic process in rats and mice. The process of identifying chemicals that cause toxicity or carcinogenicity in rodents is quite well established. However, there has been lot of debate among learned and concerned scientists both in the regulatory and the regulated community with respect to extrapolating these data for risk management decisions in the protection of human health.

×

References

×

Citation

Citation: KS Rao. “Potential Sunset of 2-Year Carcinogenicity Studies in Rodents for Small Molecule Pharma Compounds”. Acta Scientific Pharmacology 1.3 (2020):12-13.





Indexed In


News and Events


  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.

Contact US